These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 16400423

  • 1. [Proton spectroscopy in Alzheimer's disease and cognitive impairment not dementia: a community study].
    Azevedo D, Bottino CM, Tatsch M, Hototian SR, Bazzarella MC, Castro CC.
    Arq Neuropsiquiatr; 2005 Dec; 63(4):1021-7. PubMed ID: 16400423
    [Abstract] [Full Text] [Related]

  • 2. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
    Azevedo D, Tatsch M, Hototian SR, Bazzarella MC, Castro CC, Bottino CM.
    Dement Geriatr Cogn Disord; 2008 Dec; 25(6):491-500. PubMed ID: 18441524
    [Abstract] [Full Text] [Related]

  • 3. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

  • 4. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM, Gavrila D, Antúnez C, Tormo MJ, Salmerón D, Carles R, Jiménez Veiga J, Parrilla G, Torres del Río S, Fortuna L, Navarro C.
    Dement Geriatr Cogn Disord; 2008 Dec; 26(1):15-25. PubMed ID: 18566544
    [Abstract] [Full Text] [Related]

  • 5. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD, Rai GS.
    Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
    [Abstract] [Full Text] [Related]

  • 6. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP.
    Neurosci Lett; 2003 Aug; 384(1-2):23-8. PubMed ID: 15905028
    [Abstract] [Full Text] [Related]

  • 7. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
    Su L, Blamire AM, Watson R, He J, Hayes L, O'Brien JT.
    Transl Psychiatry; 2016 Aug 30; 6(8):e877. PubMed ID: 27576166
    [Abstract] [Full Text] [Related]

  • 8. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U, Bacher R, Vonbank H, Kemmler G, Lingg A, Marksteiner J.
    J Clin Psychiatry; 2003 Mar 30; 64(3):235-42. PubMed ID: 12716263
    [Abstract] [Full Text] [Related]

  • 9. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T, Xiao S, Li X, Ding B, Ling H, Chen K, Fang Y.
    Int Psychogeriatr; 2012 Jan 30; 24(1):19-27. PubMed ID: 21676281
    [Abstract] [Full Text] [Related]

  • 10. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.
    Kantarci K, Reynolds G, Petersen RC, Boeve BF, Knopman DS, Edland SD, Smith GE, Ivnik RJ, Tangalos EG, Jack CR.
    AJNR Am J Neuroradiol; 2003 May 30; 24(5):843-9. PubMed ID: 12748083
    [Abstract] [Full Text] [Related]

  • 11. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
    Foy CM, Daly EM, Glover A, O'Gorman R, Simmons A, Murphy DG, Lovestone S.
    Brain Topogr; 2011 Oct 30; 24(3-4):316-22. PubMed ID: 21298332
    [Abstract] [Full Text] [Related]

  • 12. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.
    Kantarci K, Jack CR, Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC.
    Neurology; 2000 Jul 25; 55(2):210-7. PubMed ID: 10908893
    [Abstract] [Full Text] [Related]

  • 13. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U, Lais C, Rochmont Adu M, Kratzsch T, Frölich L, Maurer K, Zanella FE, Lanfermann H, Pantel J.
    Psychiatry Res; 2009 Jul 15; 173(1):1-7. PubMed ID: 19427767
    [Abstract] [Full Text] [Related]

  • 14. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
    Metastasio A, Rinaldi P, Tarducci R, Mariani E, Feliziani FT, Cherubini A, Pelliccioli GP, Gobbi G, Senin U, Mecocci P.
    Neurobiol Aging; 2006 Jul 15; 27(7):926-32. PubMed ID: 15936850
    [Abstract] [Full Text] [Related]

  • 15. (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging.
    Catani M, Cherubini A, Howard R, Tarducci R, Pelliccioli GP, Piccirilli M, Gobbi G, Senin U, Mecocci P.
    Neuroreport; 2001 Aug 08; 12(11):2315-7. PubMed ID: 11496102
    [Abstract] [Full Text] [Related]

  • 16. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM, Heinze HJ, Kaufmann J.
    J Alzheimers Dis; 2013 Aug 08; 36(1):155-63. PubMed ID: 23579327
    [Abstract] [Full Text] [Related]

  • 17. [Alzheimer's disease and magnetic resonance spectroscopy of the hippocampus].
    Engelhardt E, Moreira DM, Laks J, Marinho VM, Rozenthal M, Oliveira AC.
    Arq Neuropsiquiatr; 2001 Dec 08; 59(4):865-70. PubMed ID: 11733829
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
    Modrego PJ, Fayed N, Pina MA.
    Am J Psychiatry; 2005 Apr 08; 162(4):667-75. PubMed ID: 15800137
    [Abstract] [Full Text] [Related]

  • 20. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
    MacKay S, Meyerhoff DJ, Constans JM, Norman D, Fein G, Weiner MW.
    Arch Neurol; 1996 Feb 08; 53(2):167-74. PubMed ID: 8639067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.